Engage Bio

Engage Bio is a biotechnology company based in San Carlos, California, specializing in the development of mRNA therapies aimed at transforming cancer cells into factories for locally acting immunotherapies. Founded in 2021 by Kathryn Kwant and Will Olsen, the company is backed by Y Combinator and focuses on innovative cancer treatments. Engage Bio's platform technology leverages messenger Ribonucleic Acid (mRNA) to create potent, safe, and programmable genetic medicines, positioning itself as a pioneer in the biotech sector. The company has a small team of five employees and is in the seed stage of development.

Recent Posts by Engage Bio

1-1 of 1